MedWatch

Analyst says acquisition strengthens Coloplast's core competencies

The acquisition of the Swedish company Atos Medical could lay the foundation for further top line growth and increased revenue for Coloplast, a Sydbank analyst assesses.

Photo: Coloplast / PR

Coloplast's acquisition of Atos Medical could prove to be a solid growth driver within the Danish medtech company's chronic care business, says Senior Analyst at Sydbank Søren Løntoft Hansen.

Atos Medical is right up Coloplast's alley when it comes to its core competencies, and could therefore pave the way for further growth in terms of top line and revenue, he assesses.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs